If drugs and vaccines take years to develop, how was the life science community able to create a novel vaccine and get multiple treatments approved in less than one year?
In this eBook, we explore how the pandemic spurred an urgency to innovate that improved clinical development in ways that should benefit the industry beyond COVID-19.
In an industry where nearly 80% of all clinical trials fail to enroll and complete on time, how were we able to get two vaccines and two treatments approved in a year?
We have used literature reviews, interviews with subject matter experts, and our direct experience working on COVID-19 vaccine and therapeutic trials to answer those questions.
OneStudyTeam, a member of the Reify Health portfolio, provides the cloud-based platform StudyTeam to accelerate the development of new and life-saving therapies. StudyTeam brings research site workflows online and enables sites, sponsors, and other key stakeholders to work together more effectively using common technology. The suite of StudyTeam solutions reduces site burden and helps sites pre-screen and enroll more patients, provides sponsors with end-to-end visibility into recruitment activity across all channels, and guides sites in conducting the trial for patients who have been enrolled. StudyTeam is trusted by the largest global biopharmaceutical companies, used in more than 6,000 research sites, and is available in over 100 countries.
One mission. One team. That’s OneStudyTeam.
33 Arch Street 17th Floor Boston, MA 02110
Join Our Mailing List
Get OneStudyTeam news and clinical trial enrollment insights delivered directly to your inbox.
Copyright © 2024 OneStudyTeam, Inc. All Rights Reserved.